BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17143592)

  • 1. Effects of polyamine depletion by alpha-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells.
    Jun JY; Griffith JW; Bruggeman R; Washington S; Demers LM; Verderame MF; Manni A
    Breast Cancer Res Treat; 2007 Sep; 105(1):29-36. PubMed ID: 17143592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of polyamine depletion by alpha-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells.
    Jun JY; Griffith JW; Bruggeman R; Washington S; Demers LM; Verderame MF; Manni A
    Breast Cancer Res Treat; 2008 Jan; 107(1):33-40. PubMed ID: 17333337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
    Xu H; Washington S; Verderame MF; Manni A
    Breast Cancer Res Treat; 2008 Nov; 112(2):255-61. PubMed ID: 18097746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies on the polyamine metabolism and DFMO treatment of MCF-7 and MDA-MB-231 breast cancer cell lines and xenografts.
    Kremmer T; Pälyi I; Daubner D; Boldizsár M; Vincze B; Paulik E; Sugár J; Pokorny E; Túry E
    Anticancer Res; 1991; 11(5):1807-13. PubMed ID: 1768053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO.
    Weeks RS; Vanderwerf SM; Carlson CL; Burns MR; O'Day CL; Cai F; Devens BH; Webb HK
    Exp Cell Res; 2000 Nov; 261(1):293-302. PubMed ID: 11082299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of alpha-difluoromethylornithine on the in vivo uptake of 14C-labeled polyamines and methylglyoxal bis(guanylhydrazone) by a rat prostate-derived tumor.
    Heston WD; Kadmon D; Covey DF; Fair WR
    Cancer Res; 1984 Mar; 44(3):1034-40. PubMed ID: 6420052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice.
    Sunkara PS; Rosenberger AL
    Cancer Res; 1987 Feb; 47(4):933-5. PubMed ID: 3100031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
    Heston WD; Fleischmann J; Tackett RE; Ratliff TL
    Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual and combined effects of alpha-difluoromethylornithine and ovariectomy on the growth and polyamine milieu of experimental breast cancer in rats.
    Manni A; Badger B; Glikman P; Bartholomew M; Santner S; Demers L
    Cancer Res; 1989 Jul; 49(13):3529-34. PubMed ID: 2499419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of polyamine homologues on the prevention of DL-alpha-difluoromethylornithine-mediated inhibition of malignant cell growth and normal immune response.
    Singh AB; Thomas TJ; Thomas T; Singh M; Mann RA
    Cancer Res; 1992 Apr; 52(7):1840-7. PubMed ID: 1551114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of polyamine synthesis inhibitors on primary tumor features and metastatic capacity of human breast cancer cells.
    Manni A; Washington S; Hu X; Griffith JW; Bruggeman R; Demers LM; Mauger D; Verderame MF
    Clin Exp Metastasis; 2005; 22(3):255-63. PubMed ID: 16158253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between heat sensitivity and polyamine levels after treatment with alpha-difluoromethylornithine (DFMO).
    Mivechi NF; Dewey WC; Feuerstein BG; Deen DF; Marton LJ
    Radiat Res; 1986 Dec; 108(3):269-81. PubMed ID: 3099327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-difluoromethylornithine as treatment for metastatic breast cancer patients.
    O'Shaughnessy JA; Demers LM; Jones SE; Arseneau J; Khandelwal P; George T; Gersh R; Mauger D; Manni A
    Clin Cancer Res; 1999 Nov; 5(11):3438-44. PubMed ID: 10589756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gastrointestinal polyamine source depletion enhances DFMO induced polyamine depletion in MCF-7 human breast cancer cells in vivo.
    Levêque J; Burtin F; Catros-Quemener V; Havouis R; Moulinoux JP
    Anticancer Res; 1998; 18(4A):2663-8. PubMed ID: 9703925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyamine depletion inhibits apoptosis following blocking of survival pathways in human chondrocytes stimulated by tumor necrosis factor-alpha.
    Stanic I; Facchini A; Borzì RM; Vitellozzi R; Stefanelli C; Goldring MB; Guarnieri C; Facchini A; Flamigni F
    J Cell Physiol; 2006 Jan; 206(1):138-46. PubMed ID: 15965903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological activity of the S-adenosylmethionine decarboxylase inhibitor SAM486A in human breast cancer cells in vitro and in vivo.
    Hu X; Washington S; Verderame MF; Demers LM; Mauger D; Manni A
    Int J Oncol; 2004 Dec; 25(6):1831-8. PubMed ID: 15547724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic inhibition of polyamine synthesis and growth by difluoromethylornithine plus methylthioadenosine in methylthioadenosine phosphorylase-deficient murine lymphoma cells.
    Yamanaka H; Kubota M; Carson DA
    Cancer Res; 1987 Apr; 47(7):1771-4. PubMed ID: 3102048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of F9 embryonal carcinoma cell differentiation by inhibition of polyamine synthesis.
    Oredsson SM; Billgren M; Heby O
    Eur J Cell Biol; 1985 Sep; 38(2):335-43. PubMed ID: 3930245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered cell cycle phase distributions in cultured human carcinoma cells partially depleted of polyamines by treatment with difluoromethylornithine.
    Seidenfeld J; Block AL; Komar KA; Naujokas MF
    Cancer Res; 1986 Jan; 46(1):47-53. PubMed ID: 3079590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment.
    Richert MM; Phadke PA; Matters G; DiGirolamo DJ; Washington S; Demers LM; Bond JS; Manni A; Welch DR
    Breast Cancer Res; 2005; 7(5):R819-27. PubMed ID: 16168128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.